SCHEMBL21189196

SCHEMBL21189196

COC(=O)N[C@H]1CCOc2c(C(=O)Nc3ccc(F)c(F)c3)c(F)cc(F)c21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 1/20 0.41
FPR1 P21462 1/20 0.39
FPR2 P25090 1/20 0.39
RAB9A P51151 6/20 0.39
NPC1 O15118 5/20 0.39
LMNA P02545 1/20 0.39
CASP3 P42574 1/20 0.39
SENP8 Q96LD8 1/20 0.39
SENP7 Q9BQF6 1/20 0.39
SENP6 Q9GZR1 1/20 0.39
SMN1; SMN2 Q16637 4/20 0.38
MEN1 O00255 4/20 0.38
KMT2A Q03164 4/20 0.38
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38
ALDH1A1 P00352 3/20 0.37
TP53 P04637 1/20 0.37
GLA P06280 1/20 0.37
HCRTR1 O43613 1/20 0.36
HCRTR2 O43614 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19973576 0.89 MAOB (0.39) MAOBFPR1FPR2RAB9ANPC1
SCHEMBL19973491 0.89 MAOB (0.43) MAOBRAB9ANPC1LMNACASP3
SCHEMBL19973492 0.89 MAOB (0.43) MAOBRAB9ANPC1LMNACASP3
SCHEMBL19973997 0.88 MAOB (0.41) MAOBFPR1FPR2RAB9ANPC1
SCHEMBL19973998 0.88 MAOB (0.41) MAOBFPR1FPR2RAB9ANPC1
SCHEMBL21189268 0.87 RAB9A (0.42) MAOBRAB9ANPC1LMNACASP3
SCHEMBL21189237 0.87 RAB9A (0.42) MAOBRAB9ANPC1LMNACASP3
SCHEMBL21189343 0.87 MAOB (0.42) MAOBFPR1FPR2RAB9ANPC1
SCHEMBL21189527 0.87 MAOB (0.42) MAOBFPR1FPR2RAB9ANPC1
SCHEMBL21189392 0.87 MAOB (0.42) MAOBFPR1FPR2RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11001564-B2 Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same ARBUTUS BIOPHARMA CORPORATION (CA) 2021-05-11 US disclosed
US-20190225593-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA CORP (CA) 2019-07-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190225593-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME CBX8, HAVCR2, HCCS MAOB 1792/4885FPR1 1303/4885FPR2 1600/4885
US-11001564-B2 Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same CBX8, HAVCR2, HCCS MAOB 1792/4885FPR1 1303/4885FPR2 1600/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.